Treatment of cytomegalovirus infection and disease pre- and post-quantitative nucleic acid test standardization: does use of a more sensitive assay lead to longer treatment duration?-Reference-Cited by-同舟云学术

Treatment of cytomegalovirus infection and disease pre- and post-quantitative nucleic acid test standardization: does use of a more sensitive assay lead to longer treatment duration?

Published:2016-01-06 Issue:2 Volume:30 Page:154-160
ISSN:0902-0063
Container-title:Clinical Transplantation
language:en
Short-container-title:Clin Transplant

Author:

Dioverti M. Veronica¹,Lahr Brian²,Razonable Raymund R.¹³

Affiliation:

1. Division of Infectious Diseases; Department of Medicine; Mayo Clinic; Rochester MN USA

2. Biomedical Statistics and Informatics; Department of Biostatistics; Mayo Clinic; Rochester MN USA

3. Department of Health Sciences Research; The William J. Von Liebig Center for Transplantation and Clinical Regeneration; Mayo Clinic; Rochester MN USA

Publisher

Wiley

Subject

Transplantation

Reference14 articles.

1. Cytomegalovirus in solid organ transplantation;Razonable;Am J Transplant,2013

2. Updated international consensus guidelines on the management of cytomegalovirus in solid-organ transplantation;Kotton;Transplantation,2013

3. Management strategies for cytomegalovirus infection and disease in solid organ transplant recipients;Razonable;Infect Dis Clin North Am,2013

4. Clinical utility of viral load in management of cytomegalovirus infection after solid organ transplantation;Razonable;Clin Microbiol Rev,2013

5. An international multicenter performance analysis of cytomegalovirus load tests;Hirsch;Clin Infect Dis,2013

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prevention of Cytomegalovirus Infection in Solid Organ Transplant Recipients: Guidelines by the Korean Society of Infectious Diseases and the Korean Society for Transplantation;Infection & Chemotherapy;2024

2. Transition from antigenemia to quantitative nucleic acid amplification testing in cytomegalovirus-seropositive kidney transplant recipients receiving preemptive therapy for cytomegalovirus infection;Scientific Reports;2022-07-27

3. Cytomegalovirus in Solid Organ Transplant Recipients: Clinical Updates, Challenges and Future Directions;Current Pharmaceutical Design;2020-08-31

4. Cytomegalovirus in Adult Allogeneic Blood and Marrow Transplant Patients Before or Around the Period of Neutrophil Recovery: A Single-Center, Retrospective, Descriptive Study;Open Forum Infectious Diseases;2020-03-01

5. Cytomegalovirus in solid organ transplant recipients—Guidelines of the American Society of Transplantation Infectious Diseases Community of Practice;Clinical Transplantation;2019-03-28